• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2300059 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2023-07-26 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSL2500240 流感病毒裂解疫苗(BK-01佐剂) Other Biological Products(3.2) New Drug Application 2025-03-22 Changchun BCHT Biotechnology Co view
CYSB2101228 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2021-10-21 Shanghai Institute of Biological Products Co Ltd view
CYSB2400251 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2024-09-25 Shanghai Institute of Biological Products Co Ltd view
CYSB2300198 甲型H1N1流感病毒裂解疫苗 H1N1 Influenza A Vaccine(Split Virion),Inactivated Injection Biological Products Supplementary Application 2023-10-31 Shanghai Institute of Biological Products Co Ltd view
CYSB2101186 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2021-09-13 Jiangsu Gdk Biological Technology Co Ltd view
CXSL2500509 流感病毒裂解疫苗(高剂量) influenza vaccine(split virion),inactivated Injection Biological Products(3.2) New Drug Application 2025-06-24 Wuhan Institute of Biological Products Co Ltd view
CYSB2200115 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2022-05-05 Sinovac Biotech Co Ltd view
CXSS2400121 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products(3.3) New Drug Application 2024-11-14 Wuhan Institute of Biological Products Co Ltd view
CXSS2101001 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.2) New Drug Application 2021-05-17 Hualan Biological Bacterin Inc view
CXSL2400247 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products(3.3) New Drug Application 2024-04-19 Wuhan Institute of Biological Products Co Ltd view
CXSL2300218 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) New Drug Application 2023-03-28 Institute of Medical Biology Chinese Academy of Medical Sciences view
CYSB2500052 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2025-03-07 Shanghai Institute of Biological Products Co Ltd view
CXSL2200240 四价流感病毒裂解疫苗(MDCK细胞) influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(2.2) New Drug Application 2022-06-03 Lanzhou Bailing Biotechnology Co Ltd;Wuhan Institute of Biological Products Co Ltd;Northwest University For Nationalities view
CYSB2400211 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2024-08-09 Sinovac Biotech Co Ltd view
CYSB2300178 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2023-10-10 Shanghai Institute of Biological Products Co Ltd view
CYSB2200031 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2022-01-30 Zhejiang Tianyuan BIO-PHARMACEUTICAL Co Ltd view
CYSB2500089 流感病毒裂解疫苗 influenza vaccine(split virion),inactivated Injection Biological Products Supplementary Application 2025-04-26 Shenzhen Sanofi Pasteur Biological Products Co Ltd view
CYSB2200177 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products Supplementary Application 2022-07-18 Sinovac Biotech Co Ltd view
CXSB2400126 四价流感病毒裂解疫苗 influenza vaccine(split virion),inactivated,quadrivalent Injection Biological Products(3.3) Supplementary Application 2024-10-18 Aleph Biomedical Company Limited view